Auna股東大會全數議案通過 兩名董事辭任 董事會維持七人獨立多數

EX-99.1
2
dp249806_ex9901.htm
EXHIBIT 99.1

 

Exhibit 99.1

 

 

 

 

Auna
Announces Results of Annual General Meeting and Board Composition Update

 

 

Luxembourg–
July 7, 2026 - Auna S.A. (“Auna” or the “Company”) (NYSE: AUNA), a Latin American healthcare company with
operations in Mexico, Peru and Colombia, announced today the results of its annual general meeting of shareholders held on June 30, 2026
(the “Annual General Meeting”). The Company’s shareholders approved and adopted all of the matters submitted to them,
as described below.

 

1.Convening
 formalities. The shareholders confirmed that the Annual General Meeting had been duly convened
 and validly constituted.

 

2.Confirmation
 of share awards to independent directors. The shareholders confirmed the share awards granted
 to the independent directors, as approved by the board of directors of the Company (the “Board”),
 with the directors concerned having abstained under Article 441-7 of the Luxembourg law of
 August 10, 1915 on commercial companies, as amended.

 

3.Approval
 of the 2025 reports, accounts and allocation of the result. The shareholders approved the
 Board’s management reports and the reports of the statutory auditor of the Company
 (the “Statutory Auditor”) and the contractual auditor for the financial year
 ended December 31, 2025 (the “2025 Financial Year”); approved the Company’s
 separate annual accounts and its consolidated financial statements prepared for Luxembourg
 regulatory purposes and for the information of investors; and resolved on the allocation
 of the result for the 2025 Financial Year as proposed by the Board.

 

4.Discharge
 to the directors. The shareholders granted discharge to the directors for the performance
 of their mandate for the 2025 Financial Year.

 

5.Discharge
 and reappointment of the Statutory Auditor. The shareholders granted discharge to the Statutory
 Auditor for the 2025 Financial Year and reappointed it for the financial year ending December
 31, 2026, until the annual general meeting to be held in 2027.

 

6.Ratification
 of remuneration and compensation. The shareholders ratified the directors’ remuneration
 and the compensation granted to certain directors by the Compensation and Talent Committee
 and approved by the Board for the 2025 Financial Year.

 

7.Miscellaneous.
 No other business was transacted at the Annual General Meeting.

 

  

  

  

 

Board
Composition Update

 

Separately,
the Board has determined that a seven-member Board is appropriate for Auna at this time. Accordingly, Jorge Basadre and Guadalupe Phillips
have stepped down from the Board, effective July 6, 2026. The Board does not intend, at this time, to fill the resulting vacancies.

 

Following
these changes, the Board continues to have a majority of independent directors.

 

The
Board and management team thank Jorge and Guadalupe for their service and contributions to Auna during an important period for the Company
and wish them continued success in their future endeavors.

 

About
Auna 

 

Auna
is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention
and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering
access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989,
Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical
care centers and a vertically integrated portfolio of oncology and general health plans. As of March 31, 2026, Auna’s network included
31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,337 beds and
1.4 million health plan members.

 

For
more information visit www.aunainvestors.com

 

Investor
Relations Contact [email protected]